Delivery Order SPE2DB22D1202-SPE2DB25FUKZ3
Award Date
11/27/24
Potential Completion Date
11/29/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,126.91, is a Firm Fixed Price Delivery Order for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.38 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, with a period of performance through March 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract award, valued at $1,144.75, is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price Delivery Order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.44 firm fixed-price delivery order is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $2,161.86 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity, to support military healthcare programs. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The contract has a ceiling value of $12,297.32 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award, valued at $1,125.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, and has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,742.82 firm fixed-price contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medication, with a performance period through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,143.73, is a delivery order for the pharmaceutical product DIPRIVAN 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of October 26, 2023 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical care medication. The $6,771.10 firm-fixed-price delivery order has a completion date of July 30, 2024 and is not designated as a set-aside contract. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of...